
CLP-3094
CLP-3094
Catalog No. M28591
CLP-3094 is a potent androgen receptor BF3 (binding function 3) inhibitor. BF3-IN-1 inhibits AR transcriptional activity with IC50 of 4 μM. CLP-3094 is a selective and potent GPR142 antagonist.
Size | Price / USD | Stock | Quantity |
5MG | 104 | Get Quote |
![]() ![]() |
10MG | 178 | Get Quote |
![]() ![]() |
25MG | 314 | Get Quote |
![]() ![]() |
50MG | 470 | Get Quote |
![]() ![]() |
100MG | 669 | Get Quote |
![]() ![]() |
500MG | 1341 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCLP-3094
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1.Xia XK, Liu X, Zhang YG, Yuan WP, Zhang MS, Wang XJ, Meng XM, Liu CH. [Study on the second metabolisms from fungus HS-1 Epicoccum spp. from the sea cucumber in Yellow Sea]. Zhong Yao Cai. 2010 Oct;33(10):1577-9. Chinese. PMID: 21355195.
molnova catalog



related products
-
Proxalutamide
A potent androgen receptor (AR) antagonist with ability to down regulate AR protein level in prostate cancer cells.
-
Metribolone
An orally active anabolic-androgenic steroid and a 19-nortestosterone derivative that has been widely used in scientific research as a hot ligand in androgen receptor (AR) ligand binding assays (LBAs) and as a photoaffinity label for the AR.
-
BMS-641988 B
BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.